By Cara Murez HealthDay Reporter MONDAY, June 13, 2022 (HealthDay News) — Hot flashes are one of the most well-known symptoms of menopause and they can be severe and frequent, happening throughout the day and night over several years. Researchers say they have found a new, effective treatment that could provide relief and an alternative … Read more
March 22, 2022 — The human body needs a lot of oxygen: about a cup a minute, just to stay alive. If we can’t get the amount we need because of injury or disease, like COVID-19, our bodies quickly start to suffer from oxygen deprivation. After just a few minutes, abnormally low oxygen levels in … Read more
By Amy Norton HealthDay Reporter MONDAY, March 8, 2021 (HealthDay News) — Just two weeks of treatment with an experimental drug can delay the onset of type 1 diabetes by several years, researchers report. The drug, called teplizumab, is already under review by the U.S. Food and Drug Administration based on earlier evidence of its … Read more
By Ernie Mundell HealthDay Reporter WEDNESDAY, Nov. 25, 2020 (HealthDay News) — Early in the COVID-19 pandemic, anecdotal reports suggested that infusing very sick patients with the blood plasma of people who’d survived the disease might help boost outcomes. But study findings released Nov. 24 in the New England Journal … Read more
After Jiaxing, emergency use of China’s experimental Covid-19 vaccines has been approved for the cities of Yiwu, Ningbo, and Shaoxing. [REPRESENTATIVE IMAGE] File photo of locals wearing face-masks in Beijing (Photo Credits: AP) China on Sunday ramped up the usage of its experimental Covid-19 vaccines to three more cities for urgent use. This announcement comes … Read more
A division of Chinese state-run Sinopharm Group Co Ltd, which is developing two Covid-19 vaccines, is offering them for free to Chinese students going abroad for higher studies, as per a report. The announcement of the company distributing vaccines to students appeared on a website where people could sign up to receive it, the Wall … Read more
Professor Martin Landray, from the University of Oxford professor, is co-leading the UK trial of the monoclonal antibody treatment, which is being used on President Trump. Professor Landray said the Regeneron drug helps stops the virus getting into cells, and has shown “promising results” in trials. Source link